Clinical trial supported by Reverse Rett
Reverse Rett are currently supporting the first UK clinical trial for a potential treatment for Rett Syndrome, the Sarizotan Clinical Trial (STARS) which is taking place at King's College Hospital in London, under the leadership of Dr Santosh. The STARS study is sponsored by Newron Pharmaceuticals.
Reverse Rett are supporting the study by:
The STARS study is a multi-centre, international clinical trial. The UK trial site is currently recruiting patients age 13 and over only. However, we are seeking expressions of interest from families of patients from the age of 6 to 13.
If you have a child with Rett who has breathing irregularities in this age group and you have not yet registered them on the UK Rett Syndrome Patient Registry at Reverse Rett, please register today.